New Zealand Gazette – 2008 – No. 127

Page 3300

✨ Medicines Classification

NEW ZEALAND GAZETTE, No. 127

14 AUGUST 2008

Hydrocortisone and hydrocortisone acetate but no other esters of hydrocortisone; for dermal use in medicines containing 1% or less but more than 0.5% by weight of hydrocortisone base with no other ingredient except an antifungal and in a quantity of 30 grams or less or 30 millilitres or less per container; in rectal medicines containing 1% or less but more than 0.5% by weight of hydrocortisone base and in combination with a local anaesthetic and in a quantity of 35 grams or less per container or up to 12 suppositories per pack

*Ibuprofen; for oral use in tablets or capsules containing up to 400 milligrams per dose form and in packs containing not more than 50 dose units and which have received the consent of the Minister or the Director-General to their distribution as restricted medicines and are sold in the manufacturer’s original pack labelled for use by adults and children over 12 years of age

Levonorgestrel; in medicines for use as emergency post-coital contraception when in packs containing not more than 1.5 milligrams except when sold by nurses recognised by their professional body as having competency in the field of sexual and reproductive health

Mepyramine; for oral use in medicines for adults and children over 2 years of age

Nicotinic acid except nicotinamide; in medicines containing 250 milligrams or less but more than 100 milligrams per dose form

Oxiconazole; for vaginal use

Pheniramine; for oral use in medicines for adults and children over 2 years of age

Prochlorperazine; in packs containing not more than 10 tablets or capsules for the treatment of nausea associated with migraine

Promethazine; for oral use in medicines for adults and children over 2 years of age except when specified elsewhere in this Schedule

Salicylic acid; except in medicines for dermal use containing 40% or less

*Sumatriptan; for oral use in medicines for the acute relief of migraine attacks with or without aura in patients who have a stable, well-established pattern of symptoms when in tablets containing 50 milligrams or less per tablet and when sold in a pack containing not more than 2 tablets which has received the consent of the Minister or the Director-General to its sale as a restricted medicine

Trimeprazine; for oral use in medicines for adults and children over 2 years of age

Triprolidine; for oral use in medicines for adults and children over 2 years of age except when specified elsewhere in this Schedule

Schedule 3

Pharmacy-only Medicines

Antazoline; for ophthalmic use except when sold in practice by a registered optometrist

*Beclomethasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age when in aqueous nasal sprays delivering up to 50 micrograms per actuation and when the maximum recommended daily dose is no greater than 400 micrograms and the medicine has received the consent of the Minister or the Director-General to its distribution as a pharmacy-only medicine

Benzydamine; for external use except for dermal use

Brompheniramine; for oral use in medicines for adults or children over two years of age when combined in the same container with one or more other therapeutically active ingredient either when in the bedtime dose of a day-night pack containing brompheniramine or when at least one of the other therapeutically active ingredients is a sympathomimetic decongestant

*Budesonide; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age when in aqueous nasal sprays delivering up to 50 micrograms per actuation and when the maximum recommended daily dose is no greater than 400 micrograms and the medicine has received the consent of the Minister or the Director-General to its distribution as a pharmacy-only medicine

Chlorpheniramine; for oral use in medicines for adults and children over 2 years of age when combined in the same container with one or more other therapeutically active ingredient either when in the bedtime dose of a day-night pack containing chlorpheniramine or when at least one of the other therapeutically active ingredients is a sympathomimetic decongestant

Clotrimazole; for external use except in medicines for tinea pedis only

Dexchlorpheniramine; for oral use in medicines for adults and children over 2 years of age when combined in the same container with one or more other therapeutically active ingredient either when in the bedtime dose of a day-night pack containing dexchlorpheniramine or when at least one of the other therapeutically active ingredients is a sympathomimetic decongestant

Dibromopropamidine; for ophthalmic use except when sold in practice by a registered optometrist

Diclofenac; in solid dose form in medicines containing 12.5 milligrams or less per dose form in packs containing not more than 20 tablets or capsules and with a recommended daily dose of not more than 75 milligrams

Dimenhydrinate; for oral use in a sealed container of not more than 10 tablets or capsules for the prevention or treatment of motion sickness in adults and children over 2 years of age except when sold at a transport terminal or aboard a ship or plane

Diphenhydramine; for oral use in medicines for adults and children over 2 years of age when combined in the same container with one or more other therapeutically active ingredient either when in the bedtime dose of a day-night pack containing diphenhydramine or when at least one of the other therapeutically active ingredients is a sympathomimetic decongestant; for oral use in a sealed container of not more than 10 tablets or capsules of diphenhydramine theoclate for the prevention or treatment of motion sickness in adults and children over 2 years of age except when sold at a transport terminal or aboard a ship or plane

Diphenylpyraline; for oral use in medicines for adults and children over 2 years of age when combined in the same container with one or more other therapeutically active ingredient either when in the bedtime dose of a day-night pack containing diphenylpyraline or when at least one of the other therapeutically active ingredients is a sympathomimetic decongestant

Doxylamine; for oral use in medicines for adults and children over 2 years of age when combined in the same container with one or more other therapeutically active ingredient either when in the bedtime dose of a day-night pack containing doxylamine or when at least one of the other therapeutically active ingredients is a sympathomimetic decongestant

*Fluticasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age when

Gazette.govt.nz — NZ Gazette 2008, No 127

The Executive Wing of Parliament (depicted) is universally known as The Beehive. It was completed in 1977 and remains the primary office for the elected Government of the day.

✨ LLM interpretation of page content

🏥 Classification of Medicines under Medicines Act 1981 (continued from previous page)

Domain🏥 Health & Social Welfare
KeywordsMedicines, Classification, Prescription, Restricted, Pharmacy-only

As the Gazette has been published for more than 185 years, copyright status depends on the publication date of each issue:

1840–1925 (Public Domain): Issues of the New Zealand Gazette and Provincial Gazettes from this period are in the public domain, as the term of Crown copyright (100 years) has expired. Mechanical reproductions (e.g., scanned PDFs) of these public domain documents do not attract new copyright.
1926–1999 (Crown Copyright): Issues from this period remain subject to Crown copyright. Usage of these issues in this project is "Fair Dealing" for research purposes and consistent with the spirit of the open-access principles championed by NZGOAL, ie, "The default licensing position under ... NZGOAL is the Creative Commons Attribution 4.0 International licence ... [t]o the greatest extent possible, agencies should apply this licence to copyright material on their websites"
2000–Present (CC-BY 3.0 NZ): Gazette issues published on gazette.govt.nz are Crown copyright but are explicitly licensed by the Department of Internal Affairs under the Creative Commons Attribution 3.0 New Zealand licence (CC-BY 3.0 NZ). This project redistributes this content in accordance with those terms.

Nothing in this project is intended to infringe copyright, trademark law or personal privacy. Please contact me immediately if you have any concerns.

Third-Party Content

Where third-party content (e.g., notices submitted by external organisations) is identified within the Gazette, users should satisfy themselves regarding the copyright status of that specific content, as it may be subject to different ownership terms than the Gazette itself.

Sources and Attribution

NZ Gazette Sources

The primary sources for the issues of the NZ Gazette indexed by this project are:

New Zealand Gazette Archive, provided by Victoria University Library, copyright 2008 LexisNexis NZ Limited, Crown Copyright of New Zealand Gazette Office
- Issues from 1841-2008, including the New Munster, New Ulster, and Provincial Gazettes
New Zealand Gazettes by New Zealand Legal Information Institute (note: "NZLII is not the copyright owner in the source documents published on NZLII")
- Issues from 1913-1999
Gazette.govt.nz, Crown copyright / licensed by the Department of Internal Affairs under CC-BY 3.0 NZ
- Issues from 2000-2017

Additional Sources

Wellington City Recollect have made available a comprehensive and excellent-quality scan of the Wellington Provincial Gazette which was used to fill in a number of issues missing from Victoria University's Gazette Archive; in particular, all 1856 issues, issues 22-34 for 1864 and issues 9-19 for 1870.
27 issues of The New Zealand Advertiser and Bay of Islands Gazette (1840) were sourced from Papers Past (public domain).
Gazette Extraordinary No. 1 (1840), held at the Alexander Turnbull Library, Wellington, New Zealand. Imaged by Luke Howison at the National Library reading rooms; PDF released into the public domain.

PDF Icon

The PDF PDF Icon was made by Good Ware, CC BY-SA 4.0.

Masthead

The logo in the header is an edited version of “Winning Coat of Arms Competition Entry, 1908” by Archives New Zealand, CC BY 2.0 (found via Wikipedia).

Who made this?

I'm Luke Howison, a freelance web developer with an interest in genealogy. I have created several websites for genealogical research, such as NZ Ancestor Search Helper.

New Zealand Gazette Index